Improvement of Hailey-Hailey disease with low-dose naltrexone
Br J Dermatol
.
2020 Jun;182(6):1500-1502.
doi: 10.1111/bjd.18861.
Epub 2020 Feb 3.
Authors
M Jasans-Barceló
1
,
P Curman
2
3
,
L Hagströmer
1
,
J D Wikstrom
2
3
,
D Sairafi
1
4
Affiliations
1
Department of Dermatology and Venereology, Södersjukhuset, Stockholm, Sweden.
2
Dermatology and Venereology Section, Department of Medicine (Solna), Karolinska Institute, Stockholm, Sweden.
3
Dermato-Venereology, Karolinska University Hospital, Stockholm, Sweden.
4
Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institute, Stockholm, Sweden.
PMID:
31912486
DOI:
10.1111/bjd.18861
No abstract available
Publication types
Letter
MeSH terms
Humans
Naltrexone*
Narcotic Antagonists
Pemphigus, Benign Familial* / drug therapy
Treatment Outcome
Substances
Narcotic Antagonists
Naltrexone